Glenmark Pharmaceuticals has informed that it has enclosed a media release on 28th January 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg’ which is self-explanatory.
The above information is a part of company’s filings submitted to BSE.